Data / Form D filings / Cloverleaf Bio, Inc.
Cloverleaf Bio, Inc.: Form D filing
Cloverleaf Bio, Inc., a biotechnology company in New Haven, CT, filed a Form D with the SEC in 2026. The latest, on September 9, 2026, reports $14.8 million sold of a $29.6 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 COLLEGE STREET, #210, New Haven, CT, 06510
- Phone
- (347) 596-9754
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2153574
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | New notice | $29,599,977 | $14,799,988 | $14,799,989 | 12 | Aug 24, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Austin Draycott | Executive Officer, Director | |
| Cole Lewis | Executive Officer | |
| Dima Kuzmin | Director | |
| Christina Vorvis | Director | |
| Matthias Samwer | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
Every Form D from the week of Sep 7, 2026 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cloverleaf Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.